Literature DB >> 11756881

Assessment of macular function by multifocal electroretinogram before and after epimacular membrane surgery.

M Moschos1, M Apostolopoulos, J Ladas, P Theodossiadis, J Malias, M Moschos1, A Papaspirou, G Theodossiadis.   

Abstract

PURPOSE: To evaluate macular function before and after successful surgical peeling of idiopathic epimacular membranes by means of multifocal electroretinogram (ERG) and measuring the first order Kernel.
METHODS: Multifocal ERG of 10 patients (10 eyes) with idiopathic epimacular membrane were recorded before and after successful macular peeling. The retinal response densities of areas 1 and 2 were compared pre- and postoperatively and the functional state of the retina beneath the epimacular membrane was evaluated. The postoperative period was 3-6 months.
RESULTS: Preoperatively, the electrical retinal response densities in the foveal and the perifoveal area were apparently decreased. After a mean postoperative period of 3 months the electrical response densities of the above areas improved. This improvement continued 6 months after the operation.
CONCLUSION: In idiopathic epimacular membranes, the decrease in retinal electrophysiologic response was not limited to the fovea but also involved the perifoveal area. The electrical retinal response density of these areas gradually improved after peeling of the epimacular membrane.

Entities:  

Mesh:

Year:  2001        PMID: 11756881     DOI: 10.1097/00006982-200112000-00005

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  8 in total

1.  Pattern VEPs before and after idiopathic epiretinal membrane removal.

Authors:  Masahiro Suami; Atsushi Mizota; Yoshihiro Hotta; Minoru Tanaka
Journal:  Doc Ophthalmol       Date:  2007-01-11       Impact factor: 2.379

2.  Correlation of retinal sensitivity with visual acuity and macular thickness in eyes with idiopathic epimacular membrane.

Authors:  Murat Karacorlu; Hakan Ozdemir; Fevzi Senturk; Serra Arf Karacorlu; Omer Uysal
Journal:  Int Ophthalmol       Date:  2009-12-30       Impact factor: 2.031

3.  Assessment of macular function by multifocal electroretinography following epiretinal membrane surgery with indocyanine green-assisted internal limiting membrane peeling.

Authors:  Timothy Y Y Lai; Alvin K H Kwok; Amy W H Au; Dennis S C Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-05-17       Impact factor: 3.117

4.  Indocyanine green-assisted epiretinal membrane peeling evaluated by optical coherence tomography and multifocal electroretinography.

Authors:  Chryssanthi N Koutsandrea; Michael N Apostolopoulos; Dimitrios A Alonistiotis; Marilita M Moschos; Efstratia Georgiadou; Theodora E Kyriaki; Gerasimos T Georgopoulos; Michael N Moschos
Journal:  Clin Ophthalmol       Date:  2007-12

5.  Functional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuity.

Authors:  Beatrix Feigl; Amanda Greaves; Brian Brown
Journal:  Clin Ophthalmol       Date:  2007-06

6.  Assessment of macular function by multifocal electroretinography following epiretinal membrane surgery with internal limiting membrane peeling.

Authors:  Ji Won Lim; Joon Hee Cho; Ha Kyoung Kim
Journal:  Clin Ophthalmol       Date:  2010-07-30

7.  Assessment of macular function in patients with idiopathic Epiretinal membrane by multifocal Electroretinography: correlation with visual acuity and optical coherence tomography.

Authors:  Meng Gao; Yi Wang; Wu Liu; LiMei Liu; WeiYu Yan; Ju Liu; KeGao Liu; XinXin Liu; YanHua Hu
Journal:  BMC Ophthalmol       Date:  2017-11-28       Impact factor: 2.209

8.  Assessment of macular function, structure and predictive value of pattern electroretinogram parameters for postoperative visual acuity in patients with idiopathic epimacular membrane.

Authors:  Wojciech Lubiński; Wojciech Gosławski; Karol Krzystolik; Maciej Mularczyk; Leszek Kuprjanowicz; Michał Post
Journal:  Doc Ophthalmol       Date:  2016-04-28       Impact factor: 2.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.